| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.074 | 0.6 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |